|
Volumn 325, Issue 7367, 2002, Pages 762-
|
An overview of antithrombotic therapy
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ADENOSINE DIPHOSPHATE;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ARGATROBAN;
CLOPIDOGREL;
CYCLIC AMP;
DIPYRIDAMOLE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HIRUDIN;
HIRULOG;
ILOPROST;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
PROSTACYCLIN;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PURINERGIC RECEPTOR AFFECTING AGENT;
STREPTOKINASE;
SULFINPYRAZONE;
THROMBOXANE A2;
TICLOPIDINE;
TISSUE PLASMINOGEN ACTIVATOR;
WARFARIN;
ALOPECIA;
ANTICOAGULANT THERAPY;
BLEEDING;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
DRUG MECHANISM;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
LEUKOPENIA;
OSTEOPOROSIS;
PRIORITY JOURNAL;
PURPURA;
RASH;
REVIEW;
STROKE;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTOPENIA;
THROMBOGENESIS;
THROMBOSIS;
VASODILATATION;
ANTICOAGULANTS;
FIBRINOLYTIC AGENTS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
THROMBOSIS;
|
EID: 85007755756
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.325.7367.762 Document Type: Article |
Times cited : (115)
|
References (1)
|